HACKENSACK, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTC: RGBO) (“ReGen”) announced that the official U.S. product launch of its Menaflex™ collagen scaffold device will take place at the American Academy of Orthopaedic Surgeons (“AAOS”) annual meeting February 25-28 in Las Vegas, Nevada. The Menaflex™ device received FDA clearance in mid-December 2008.
